Overview
What is Tirzepatide?
GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 are both incretin hormones released after meals. Tirzepatide activates both receptors simultaneously with a unique unimolecular structure. The GIP component may enhance insulin secretion, promote fatty acid storage in adipose tissue (reducing ectopic fat deposition), and reduce GI side effects compared to GLP-1 monotherapy.
Research interest spans metabolic regulation, weight management mechanisms, potential hepatic effects (NAFLD/NASH), and cardiovascular risk reduction. It has demonstrated substantial weight reduction in Phase 3 trials. Dose titration over 4–5 months from 2.5 mg to target dose is the standard research approach.
🧠GLP-1 Agonism
Reduces appetite via hypothalamic GLP-1 receptors and improves pancreatic insulin secretion.
⚡GIP Agonism
Enhances incretin response, may improve lipid metabolism and reduce GI adverse effects vs GLP-1 mono.
🍽️Gastric Emptying
Slows gastric emptying, extending satiety.
❤️Metabolic Synergy
Dual mechanism may produce superior outcomes to GLP-1 alone, per Phase 3 trial data.
Reconstitution
Reconstitution Calculator
Enter your vial size and BAC water volume to calculate your exact concentration, syringe units, and number of doses per vial.
Interactive Calculator
Dose Planner for Tirzepatide
Loading…
Step-by-step
How to reconstitute
1
Gather supplies
Lyophilised peptide vial, bacteriostatic water, a drawing syringe (1–3 mL), U-100 insulin syringes for dosing, and alcohol swabs. Work on a clean surface.
2
Swab and dry
Wipe stoppers on both vials with alcohol swabs. Wait 10–15 seconds for full evaporation before piercing. Never blow or touch after swabbing.
3
Add BAC water slowly
Draw BAC water into your syringe, insert into peptide vial, and inject slowly down the inside glass wall — never directly onto the powder cake.
4
Swirl gently — do not shake
Roll the vial between your palms until powder fully dissolves. Solution should be clear and colourless. Shaking degrades the peptide.
💡 If still cloudy after 2 minutes, gently swirl again and wait. Discard if permanent cloudiness or particulates appear.
5
Label and refrigerate
Label with compound name, concentration, and reconstitution date. Store at 2–8 °C. Most reconstituted peptides are stable for 4–6 weeks refrigerated.
Dosing Protocol
Dosing Schedule
Research-derived dosing ranges. Always begin conservatively to assess tolerance.
| Phase | Dose | Frequency | Duration | Notes |
|---|
| Start month 1 | 2.5 mg | Once weekly | 4 weeks | Starting dose. Do not exceed for first month. |
| Increase | 5 mg | Once weekly | Weeks 5–8 | Standard dose for many research protocols. |
| Increase | 7.5–10 mg | Once weekly | Weeks 9–16 | Advance monthly as tolerated. |
| High dose | 12.5–15 mg | Once weekly | Week 20+ | Maximum dose studied in trials. |
🌶️
Use the PepperCalc calculatorEnter your exact vial size and BAC water above to get your precise syringe units for each dose. No guesswork.
Administration
Injection Sites
🫃
Abdomen
Lower abdominal subcutaneous fat — preferred site for consistent absorption.
🦵
Thigh
Outer thigh. Rotate weekly.
💪
Upper Arm
Outer upper arm subcutaneous fat.
Safety Profile
Safety & Side Effects
✓ Generally Well Tolerated
Well-characterised dual mechanism
Extensive Phase 3 clinical data
Once-weekly dosing
Better GI tolerability profile than some GLP-1 mono agents
⚠ Potential Concerns
Nausea and GI effects during escalation
Injection site reactions
Not suitable for personal/family history of MTC
Requires full titration schedule — cannot skip stages
⚠️
Research use onlyThis page is an educational reference. None of this constitutes medical advice. Consult a qualified professional before any use. All compounds are for research purposes only.
Recommended Source
Source your compounds at White Market Peptides
Use code PEPDOSE for 10% off + free 2-day shipping over $200
Shop Now →